Medphar SRL
Medphar reported total assets of 255,858 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Medphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +185 % Total assets -15 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 11 Oct 2023
- Year ended 31 Dec 2021filed on 31 Oct 2022
Medphar's financial analysis
- Solvency25.6%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medphar
Medphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0478.156.946
- VAT number
- BE0478156946
- Peppol
- Registered · 0208:0478156946 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Aug 2002
- Registered office
- 1030 Schaerbeek
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medphar (SRL) has been based in Schaerbeek since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,323 € and equity of 65,546 €; its revenue is not published. Its solvency stands at 25.6%, below the median of its sector (37.8%).
Companies similar to Medphar
Companies in the same business, of comparable size and area, outside its group.
- Hesbiphar Retail sale of pharmaceutical products Hannut · balance sheet 255,869 €
- Pharma VAL Retail sale of pharmaceutical products Profondeville · balance sheet 255,460 €
- Odepharma Retail sale of pharmaceutical products Koksijde · balance sheet 255,295 €
- Pharmacie Merelle Retail sale of pharmaceutical products Quévy · balance sheet 256,663 €
- MaPharma Retail sale of pharmaceutical products Charleroi · balance sheet 256,730 €
- Pharmadeville Retail sale of pharmaceutical products Bernissart · balance sheet 257,934 €
- Yasmin Libbrecht Retail sale of pharmaceutical products Antwerp · balance sheet 258,250 €
- Apotheek Van de Peer Sabine Retail sale of pharmaceutical products Edegem · balance sheet 258,424 €
Frequently asked questions about Medphar
What is the revenue of Medphar?
Medphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0478156946 for Medphar, if the company is VAT-registered. Its company number (CBE) is 0478.156.946.
Where is the registered office of Medphar?
According to the CBE register, the registered office of Medphar is in 1030 Schaerbeek.
What is the equity of Medphar?
At the close of the 2025 financial year, the equity of Medphar amounts to 65,546 €, a solvency of 25.6% of total assets.
Who manages Medphar?
The register lists 1 active mandates at Medphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →